Scientists have developed a new blood test to predict when someone is likely to show symptoms of Alzheimer’s disease, an advance that may help speed up preventive treatments.
Some 55 million people worldwide live with dementia and Alzheimer's accounts for 60-70 per cent of the cases. The number of affected people is projected to double every 20 years and reach nearly 140 million by 2050.
